首页 | 本学科首页   官方微博 | 高级检索  
检索        

培美曲塞联合顺铂治疗晚期非小细胞肺癌的临床分析
引用本文:李秀华,孙传恕,赵金波,张阳.培美曲塞联合顺铂治疗晚期非小细胞肺癌的临床分析[J].大连医科大学学报,2012,34(3):284-286.
作者姓名:李秀华  孙传恕  赵金波  张阳
作者单位:1. 大连医科大学附属第二医院肿瘤科,辽宁大连,116027
2. 大连医科大学附属第二医院影像科,辽宁大连,116027
摘    要:目的]探讨培美曲塞联合顺铂治疗晚期非小细胞肺癌的疗效和毒副反应。方法]应用培美曲塞500 mg/m2联合顺铂75 mg/m2方案治疗34例晚期非小细胞肺癌患者。结果]总有效率达38.2%,其中初治组有效率为43.7%,复治组有效率为33.3%。主要毒副反应为骨髓抑制、恶心呕吐、便秘及口腔黏膜炎等。结论]培美曲塞联合顺铂治疗晚期非小细胞肺癌有较好疗效,毒副反应可耐受。

关 键 词:非小细胞肺癌  培美曲塞  顺铂
收稿时间:2012/2/17 0:00:00
修稿时间:4/6/2012 12:00:00 AM

Clinical analysis of pemetrexed combination with cisplatin in patients with advanced non-small cell lung cancer
LI Xiu-hu,SUN Chuan-shu,ZHAO Jin-bo,ZHANG Yang.Clinical analysis of pemetrexed combination with cisplatin in patients with advanced non-small cell lung cancer[J].Journal of Dalian Medical University,2012,34(3):284-286.
Authors:LI Xiu-hu  SUN Chuan-shu  ZHAO Jin-bo  ZHANG Yang
Institution:1(1.Department of Oncology,the Second Affiliated Hospital of Dalian Medical University,Dalian 116027,China;2.Department of Radiology,the Second Affiliated Hospital of Dalian Medical University,Dalian 116027,China)
Abstract:Objective] To evaluate the efficacy and side-effect of pemetrexed combined of cisplatin in the treat of non-small cell lung cancer.Methods] A total of 34 cases of advanced non-small cell lung cancer were involved.Pemetrexed was given at a dose of 500 mg/m2,followed by cisplatin at a dose of 75 mg/m2.Results] Total efficacy was 38.2%.Among them the efficacy of the patients with current advanced non-small cell lung cancer was 43.7%,but the efficacy of recurrent patients was 33.3%.The main toxicities included bone marrow suppression,nausea and vomiting,constipation,etc.Conclusion] Pemetrexed plus cisplatin is an effective regiment for advanced NSCLC with tolerable side-effect.
Keywords:non-small cell lung cancer  pemetrexed  cisplatin
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《大连医科大学学报》浏览原始摘要信息
点击此处可从《大连医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号